Nimodipine (Caraco Pharmaceutical Laboratories, Ltd.)
Welcome to the PulseAid listing for the Nimodipine drug offered from Caraco Pharmaceutical Laboratories, Ltd.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Caraco Pharmaceutical Laboratories, Ltd. |
NON-PROPRIETARY NAME: | Nimodipine |
SUBSTANCE NAME: | NIMODIPINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2007-06-28 |
END MARKETING DATE: | 0000-00-00 |
Nimodipine HUMAN PRESCRIPTION DRUG Details:
Item Description | Nimodipine from Caraco Pharmaceutical Laboratories, Ltd. |
LABELER NAME: | Caraco Pharmaceutical Laboratories, Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/1) |
START MARKETING DATE: | 2007-06-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57664-135_b9f244e4-bf34-4f84-9507-4a56e21b8d8e |
PRODUCT NDC: | 57664-135 |
APPLICATION NUMBER: | ANDA077067 |
Other NIMODIPINE Pharmaceutical Manufacturers / Labelers: